A detailed history of Mairs & Power Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mairs & Power Inc holds 1,085,429 shares of ABT stock, worth $126 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
1,085,429
Previous 1,092,796 0.67%
Holding current value
$126 Million
Previous $114 Million 8.98%
% of portfolio
1.18%
Previous 1.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $737,215 - $870,263
-7,367 Reduced 0.67%
1,085,429 $124 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $15.8 Million - $17.6 Million
-156,877 Reduced 12.55%
1,092,796 $114 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $3.92 Million - $4.33 Million
-35,788 Reduced 2.78%
1,249,673 $142 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $1.22 Million - $1.49 Million
-13,538 Reduced 1.04%
1,285,461 $141 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $443,259 - $531,836
-4,640 Reduced 0.36%
1,298,999 $126 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $1.55 Million - $1.72 Million
-15,333 Reduced 1.16%
1,303,639 $142 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $1.25 Million - $1.48 Million
-12,948 Reduced 0.97%
1,318,972 $134 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $10.1 Million - $11.9 Million
-106,272 Reduced 7.39%
1,331,920 $146 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $907,608 - $1.05 Million
-9,380 Reduced 0.65%
1,438,192 $139 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1.6 Million - $1.93 Million
-15,657 Reduced 1.07%
1,447,572 $157 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $4.15 Million - $5.06 Million
-36,370 Reduced 2.43%
1,463,229 $173 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $1.05 Million - $1.29 Million
-9,087 Reduced 0.6%
1,499,599 $211 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $198,555 - $219,660
1,702 Added 0.11%
1,508,686 $178 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $5.88 Million - $6.92 Million
55,536 Added 3.83%
1,506,984 $175 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.03 Million - $1.22 Million
-9,497 Reduced 0.65%
1,451,448 $174 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $2.31 Million - $2.51 Million
-21,959 Reduced 1.48%
1,460,945 $160 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $9.89 Million - $12 Million
-107,916 Reduced 6.78%
1,482,904 $161 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $12.1 Million - $15.5 Million
-158,646 Reduced 9.07%
1,590,820 $145 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $12.7 Million - $18.6 Million
-202,919 Reduced 10.39%
1,749,466 $138 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $30.1 Million - $33.5 Million
-382,866 Reduced 16.4%
1,952,385 $170 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $12.7 Million - $13.7 Million
-154,768 Reduced 6.22%
2,335,251 $195 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $37.9 Million - $44.3 Million
-520,626 Reduced 17.29%
2,490,019 $209 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $10.4 Million - $12.6 Million
-156,850 Reduced 4.95%
3,010,645 $241 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $17.6 Million - $20 Million
-269,098 Reduced 7.83%
3,167,495 $229 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $24.9 Million - $30 Million
-408,755 Reduced 10.63%
3,436,593 $252 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $23.7 Million - $26.2 Million
-412,021 Reduced 9.68%
3,845,348 $235 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $16.1 Million - $18.2 Million
-286,016 Reduced 6.3%
4,257,369 $255 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $1.44 Million - $1.54 Million
-26,869 Reduced 0.59%
4,543,385 $259 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $220 Million - $245 Million
4,570,254
4,570,254 $244 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.